Genericare Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.15 M
as on 03-12-2024
- Company Age 6 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.49 Cr
as on 03-12-2024
- Revenue 22.41%
(FY 2022)
- Profit 55.60%
(FY 2022)
- Ebitda 55.55%
(FY 2022)
- Net Worth 125.80%
(FY 2022)
- Total Assets 0.52%
(FY 2022)
About Genericare Pharmacy
The Corporate was formerly known as Genricare Pharmacy Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹3.49 Cr.
Bharat Birari, Manoj Birari, Jyoti Shirke, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999MH2018PTC318184
- Company No.
318184
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Dec 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Genericare Pharmacy?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Bharat Birari | Director | 12-Dec-2018 | Current |
Manoj Birari | Director | 12-Dec-2018 | Current |
Jyoti Shirke | Director | 12-Jan-2019 | Current |
Sudhakar Birari | Director | 12-Jan-2019 | Current |
Nikita Bagul | Director | 12-Jan-2019 | Current |
Financial Performance of Genericare Pharmacy.
Genericare Pharmacy Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.41% increase. The company also saw a substantial improvement in profitability, with a 55.6% increase in profit. The company's net worth Soared by an impressive increase of 125.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Genericare Pharmacy?
In 2021, Genericare Pharmacy had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Future Generic Private LimitedActive 3 years 9 months
Bharat Birari and Manoj Birari are mutual person
- Genericare Medicine Private LimitedActive 6 years 27 days
Bharat Birari and Manoj Birari are mutual person
- 3Biz Healthcare Private LimitedActive 7 years 11 months
Bharat Birari and Manoj Birari are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Apr 2023 | ₹4.90 M | Open |
Others Creation Date: 23 Dec 2022 | ₹3.00 Cr | Open |
How Many Employees Work at Genericare Pharmacy?
Unlock and access historical data on people associated with Genericare Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genericare Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genericare Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.